- Imricor

Our Products
About Us
Newsroom
- Events
Investors
Patients
Contact

imricordevMay 12, 2020

First Commercial Procedure

Recent News

Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial
VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
Imricor Receives Approval from Saudi Food and Drug Authority

Contact Us

Name*
First Last
Title
Hospital Affiliation
Email*
Phone
City
Country
Message
CAPTCHA

Our Products

Vision-MR Ablation Catheter
Advantage-MR EP Recorder / Stimulator
Additional Products

Quick Links

About Us
Newsroom
Investors
Events
Careers
Warranty
Contact Us

Site by Hafi Design & Tela

Our Products

Vision-MR Ablation Catheter
Advantage-MR EP Recorder / Stimulator
Additional Products

Quick Links

About Us
Newsroom
Investors
Events
Careers
Warranty
Contact Us

Site by L. Finsaas Design & Tela.

Caution: The Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode have received CE mark approval and have not yet been approved for use in the United States.

Our Products
About Us
Newsroom
- Events
Investors
Patients
Contact